Clinical Trial Update: EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD [Phase 3]

View source ↗

Summary

Phase 3 trial update on low-dose oral iron for anemia in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• EffiCacy and sAfEty of Low doSe OrAL Iron for Anaemia in IBD (low-dose oral iron)

Snippet

Sponsor: Liverpool University Hospitals NHS Foundation Trust | Conditions: Inflammatory Bowel Disease, Iron Deficiency Anemia | Phase 3 | Status: UNKNOWN